Transkaryotic Therapies (NASDAQ:TKTX)
Historical Stock Chart
From May 2019 to May 2024
Notice to All Deutsche Bank Securities Inc. Clients From the
Securities Arbitration Law Firm of Klayman & Toskes, P.A.
NEW YORK, March 17 /PRNewswire/ -- The Law Firm of Klayman & Toskes, P.A.
("K&T") (http://www.nasd-law.com/ ) continues to pursue individual securities
arbitration claims before the National Association of Securities Dealers
("NASD") and the New York Stock Exchange ("NYSE") on behalf of high net worth
investors who prefer not to participate in, and investors who are ineligible to
recover from the $433 million research analyst distribution fund created by the
Securities and Exchange Commission ("SEC").
The distribution fund follows the decision against several brokerage firms
including Deutsche Bank Securities Inc. (NYSE:DB) by the SEC (SEC v. Deutsche
Bank Securities Inc, No. 04 Civ. 06909 WHP) for violation of the Securities and
Exchange Act of 1934 ("Exchange Act") and for violation of NASD rules 2110, and
2210 and NYSE rules 401, 472 and 476 (a)(6).
Although the market capitalization lost in excess of $4 billion, the
distribution fund has only allocated $28.75 million for the following stocks
purchased through Deutsche Bank Securities Inc.
1. Getty Images, Inc. (NYSE:GYI) Apr. 5, 02 - Jul. 4, 02
2. Oracle Corporation (NASDAQ:ORCL) May. 31, 01 - Aug. 29, 01
3. Transkaryotic Therapies Inc.
(NASDAQ:TKTX) Jul. 13, 01 - Oct. 11, 01
4. Trimeris, Inc (NASDAQ:TRMS) Dec. 28, 01 - Mar. 28, 02
5. Untied Therapeutics Corp. (NASDAQ:UTHR) Mar. 7, 00 - Jun. 5, 00
K&T currently represents numerous high net worth investors who have filed
individual securities arbitration claims. Investors suffering large losses
achieve an overall higher recovery rate through arbitration than any other
means. Empirical evidence shows that when an investor suffers losses in larger
amounts, usually in excess of $100,000, an individual dispute resolution
process such as an arbitration claim filed before the NYSE or the NASD may be
the best means of recovering losses suffered.
K&T has offices in California, Florida, Nebraska, and New York and represents
investors throughout the nation. The sole purpose of this release is to
investigate, on behalf of our clients, sales practice violations of licensed
brokers at major investment firms. If you wish to discuss this announcement or
have information relevant to our securities arbitration claims, please contact
Lawrence L. Klayman at 1-888-997-9956 or visit us on the web at
http://www.nasd-law.com/ .
DATASOURCE: Klayman & Toskes, P.A.
CONTACT: Lawrence L. Klayman of Klayman & Toskes, P.A., +1-888-997-9956
Web site: http://www.nasd-law.com/